{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:10:48Z","timestamp":1710493848168},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T00:00:00Z","timestamp":1247875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00393-009-0456-0","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T16:59:09Z","timestamp":1247763549000},"page":"465-470","source":"Crossref","is-referenced-by-count":3,"title":["Myasthenia gravis und myasthene Syndrome","Myasthenia gravis and myasthenic syndromes"],"prefix":"10.1007","volume":"68","author":[{"given":"W.","family":"Marouf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Sieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,18]]},"reference":[{"key":"456_CR1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.30.11.1246","volume":"30","author":"Albers","year":"1980","unstructured":"Albers JW, Hodach RJ, Kimmel DW, Treacy WL (1980) Penicillamine-associated myasthenia gravis. Neurology 30:1246\u20131250","journal-title":"Neurology"},{"key":"456_CR2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0404.1995.tb00432.x","volume":"91","author":"Christensen","year":"1995","unstructured":"Christensen PB, Jensen TS, Tsiropoulos I et al (1995) Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand 91:192\u2013195","journal-title":"Acta Neurol Scand"},{"key":"456_CR3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mus.21072","volume":"38","author":"de","year":"2008","unstructured":"de Sousa E, Howard J (2008) More evidence for the association between statins and myasthenia gravis. Muscle Nerve 38:1085\u20131086","journal-title":"Muscle Nerve"},{"key":"456_CR4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00393-005-0576-0","volume":"64","author":"Haberl","year":"2005","unstructured":"Haberl A, Ficher P, Pongratz D, Sieb JP (2005) Chloroquin-induzierte Myopathie. Folge einer siebenj\u00e4hrigen, niedrigdosierten Basistherapie bei prim\u00e4r-chronischer Polyarthritis. Z Rheumatol 64:274\u2013276","journal-title":"Z Rheumatol"},{"key":"456_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S et al (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365\u2013368","journal-title":"Nat Med"},{"key":"456_CR6","unstructured":"K\u00f6hler W, Sieb JP (2008) Myasthenia gravis, 3. Aufl. Uni-med, Bremen"},{"key":"456_CR7","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S et al (2008) IgG1 antibodies to acetylcholine receptors in \u201aseronegative\u2018 myasthenia gravis. Brain 131:1940\u20131952","journal-title":"Brain"},{"key":"456_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(05)76153-5","volume":"353","author":"Maddison","year":"1999","unstructured":"Maddison P, Newsom-Davis J, Mills KR, Souhami RL (1999) Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet 353:117\u2013118","journal-title":"Lancet"},{"key":"456_CR9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","volume":"55","author":"McConville","year":"2004","unstructured":"McConville J, Farrugia ME, Beeson D et al (2004) Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 55:580\u2013584","journal-title":"Ann Neurol"},{"key":"456_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","volume":"111","author":"O","year":"1988","unstructured":"O\u2019Neill JH, Murray NMF, Newsom-Davis J (1988) The Lambert-Eaton myasthenic syndrome. Brain 111:577\u2013596","journal-title":"Brain"},{"key":"456_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-8993(95)01349-0","volume":"712","author":"Sieb","year":"1996","unstructured":"Sieb JP, Milone M, Engel AG (1996) Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission. Brain Res 712:179\u2013189","journal-title":"Brain Res"},{"key":"456_CR12","doi-asserted-by":"crossref","unstructured":"Sieb JP, Schrank B (2009) Neuromuskul\u00e4re Erkrankungen. Kohlhammer, Stuttgart","DOI":"10.17433\/978-3-17-026656-8"},{"key":"456_CR13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-2008-1067555","volume":"39","author":"Sieb","year":"2008","unstructured":"Sieb JP, Veauthier C (2008) Lambert-Eaton-Syndrom \u2013 Aktuelles zu Diagnose und Therapie. Klin Neurophysiol 39:208\u2013218","journal-title":"Klin Neurophysiol"},{"key":"456_CR14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.64.8.1121","volume":"64","author":"Suzuki","year":"2007","unstructured":"Suzuki S, Utsugisawa K, Nagane Y et al (2007) Classification of myasthenia gravis based on autoantibody status. Arch Neurol 64:1121\u20131124","journal-title":"Arch Neurol"},{"key":"456_CR15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/jnnp.73.6.766","volume":"73","author":"Wirtz","year":"2002","unstructured":"Wirtz PW, Sotodeh M, Nijnuis M et al (2002) Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 73:766\u2013768","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-009-0456-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-009-0456-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-009-0456-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:31:15Z","timestamp":1710491475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-009-0456-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,18]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1007\/s00393-009-0456-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,18]]}}}